News

Filter

Current filters:

Refludan

1 to 9 of 25 results

Pharmion to market Refludan outside the USA and Canada

10-06-2002

Germany-based Schering AG has entered into an exclusive agreement withPharmion GmbH, a German subsidiary…

Aventis PharmaheparinLepirudinRefludanSchering Ag

FTC orders Aventis to divest Refludan

31-08-2000

The US Federal Trade Commission has ordered Aventis to divest itshirudin analog Refludan (lepirudin).…

Aventis PharmaLepirudinRefludan

US FDA issues non-approvable letter for Aventis' Refludan

25-05-2000

Aventis Pharmaceuticals of the USA has received a non-approvable letterfrom the US Food and Drug Administration…

Amino AcidsAventis PharmaheparinInjectionLepirudinPhysostigmine SalicylateRefludan

Aventis fails to gain Refludan expanded indication in the USA

04-05-2000

The US Food and Drug Administration's Cardiovascular and Renal DrugsAdvisory Committee has voted seven…

Amino AcidsAventis PharmaHamiltonheparinInjectionLepirudinPhysostigmine SalicylateRefludan

BASF ends Ph III trial of ancrod in stroke after questions raised by safety

03-04-2000

BASF Pharma says that it has discontinued a Phase III clinical trial ofits fibrinogen-lowering drug Viprinex…

ActivaseAlteplaseAmino AcidsAventis PharmaBASFGenentechheparinInjectionLepirudinPhysostigmine SalicylateRefludan

HMR files Refludan for new indication

15-07-1999

Hoechst Marion Roussel has submitted marketing applications to theEuropean Medicines Evaluation Agency…

Amino AcidsheparinInjectionLepirudinPhysostigmine SalicylateRefludan

1 to 9 of 25 results

Back to top